Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Enhancing Chronic Heart Failure Monitoring, Prevention, and Management with IoT and AI: A Systematic Literature Review
0
Zitationen
5
Autoren
2025
Jahr
Abstract
Chronic Heart Failure (CHF) represents a significant global health concern due to its high morbidity and mortality rates. Effectively addressing this challenge requires scalable technology solutions to shift Heart Failure (HF) care from episodic reactive treatment to continuous personalized management. As digital health technologies advance, integrating Artificial Intelligence (AI) and the Internet of Things (IoT) into CHF care enables the development of scalable monitoring, prevention, and management strategies and real-time Clinical Decision Support Systems (CDSSs). This Systematic Literature Review (SLR) analyzes 67 peer-reviewed studies published between January 2021 and May 2024, selected using Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to evaluate the technological and clinical impacts of AI-enabled systems in CHF and broader HF care. The review identifies emerging trends, discusses dataset characteristics and clinical relevance, identifies IoT integration patterns, gaps, and deployment barriers, and highlights opportunities for improving the integration of AI/IoT systems into HF care workflows. The studies are organized into four clinical application domains: HF detection, phenotyping and classification, risk stratification, and other miscellaneous applications. Our findings highlight the progress in AI/IoT synergy; however, challenges remain in dataset heterogeneity and coverage, reproducibility, benchmarking practices, and clinical workflow integration, particularly as IoT integration is often limited or insufficiently explored. Our primary recommendations emphasize the use of multimodal datasets, the adoption of interpretable modeling approaches, and stronger interdisciplinary collaboration to improve clinical applicability and support integration into real-world settings.
Ähnliche Arbeiten
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
2021 · 19.535 Zit.
2013 ACCF/AHA Guideline for the Management of Heart Failure
2013 · 12.581 Zit.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 12.088 Zit.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 · 11.730 Zit.
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
2002 · 11.655 Zit.